Mat Treatment Samhsa

Only sma 162s for provisional certification of a new otp can be submitted at this site.

Mat treatment samhsa.

Treatment locators find treatment facilities and programs in the united states or u s. Early serious mental illness treatment locator. Buprenorphine is a medication approved by the food and drug administration fda to treat opioid use disorder oud as a medication assisted treatment mat. For information about other medication assisted treatment mat or the certification of opioid treatment programs otps contact the samhsa division of pharmacologic therapies at 240 276 2700.

For information about other medication assisted treatment mat or the certification of opioid treatment programs otps contact the samhsa division of pharmacologic therapies at 240 276 2700. Samhsa offers a variety of training resources on medication assisted treatment mat as well as other substance use disorder treatment topics to educate and assist programs and practitioners to provide evidence based treatment. Existing otps wishing to submit form sma 162 for renewal of certification or other purposes must submit via their account on the samhsa otp extranet website at http otp extranet samhsa gov. Medication assisted treatment mat is an evidence based treatment for opioid use disorder that uses fda approved pharmacotherapy in combination with counseling and behavioral therapies to treat substance use disorders.

People who provide mat services work in a range of prevention health care and social service settings. Samhsa s division of pharmacologic therapies dpt part of samhsa s center for substance abuse treatment csat manages the day to day oversight activates required to implement federal regulations surrounding the use medications approved by the food and drug administration fda such as methadone and buprenorphine for the treatment of opioid use disorder oud for. For information about other medication assisted treatment mat or the certification of opioid treatment programs otps contact the samhsa division of pharmacologic therapies at 240 276 2700. Samhsa s division of pharmacologic therapies has published two guides for primary care and specialty providers.

Territories for mental and substance use disorders. Behavioral health treatment services locators. On the following pages you can fill out and submit to samhsa an on line form sma 162 and supporting documents for provisional initial certification of a new opioid treatment program otp. Federal statutes regulations and guidelines govern medication assisted treatment mat for opioid addiction.

Buprenorphine physician treatment program locator.